Refactor Capital β 2022 Investments
6 investments dated 2022 Β· listed companies and verified rows first Β· show all
64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.
BiotechDeep TechMedical Devices
Co-investorsBoxGroupFifty YearsFirst Round CapitalFuture VenturesLifeforce CapitalNorthpond Ventures+1 more
64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(Co-founder & CEO)in
Co-investorsFifty YearsFuture VenturesLifeforce CapitalRaptor GroupY CombinatorAlix Ventures+4 more
Evernow provides virtual menopause care for women, offering one-time video visits and ongoing membership access to certified menopause providers who prescribe hormone therapy and estrogen replacement.
Digital HealthFemTechWellness & Fitness
Alicia Jackson(Founder)in
Co-investorsNew Enterprise Associates (NEA)8VCCoelius Capital
From Yellow To Orange (fyto) is a Japanese company that produces and distributes music and video, composes and arranges music, and plans, develops, and sells games and digital content.
ConsumerGamingMedia & EntertainmentPetaluma, US
Kenji Eno(Founder)Yuka Iino(Representative Director (CEO))Jason Prapas(Executive Officer, Director)Harold Kruth(Director)Andy Wheeler(Director)
Co-investorsAgFunderFirst Star VenturesGV (Google Ventures)
Fyto develops nutrient recycling and protein production technology for farmers, enabling sustainable food production with reduced environmental impact.
AgTechClimate TechFoodTechRoboticsSan Francisco Bay Area, US
Jason Prapas(Founder)
Co-investorsCity LightAgFunderBaukunstFirst Star VenturesGV (Google Ventures)
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)in
Co-investorsAIX VenturesBreakout VenturesHumba VenturesImmeasurableJulian CapitalMetaplanet+5 more
.jpeg){kind=logo}
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.